
Chrysos
Chrysos Corporation specializes in providing advanced assay technologies and services, primarily through its flagship product, PhotonAssay™. This technology offers faster, safer, and more accurate analysis of precious metals like gold, silver, and copper, positioning Chrysos as a leader in the mining industry's technological innovation. The company's solutions are recognized for their environmental benefits and operational efficiency.
Short position
Chrysos (ASX:C79) has 0.52% of its shares on issue reported as short positions as of 5 Oct 2026, or about 605,938 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has risen 0.18 percentage points. Its highest recorded short interest was 1.32% in May 2022. C79 is classified in the Commercial & Professional Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Chrysos (C79) short interest history
C79 Short Interest History
- 30-day change
- +0.01pp
- 90-day change
- +0.18pp
- 1-year change
- +0.17pp
- All-time high
- 1.32% (May 2022)
- All-time low
- 0.00% (September 2023)
Is C79 heavily shorted?
Not especially: 0.52% short interest is modest by ASX standards, ranking #318 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.
How has C79's short interest changed recently?
Over the past 30 days Chrysos's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 0.52% of shares on issue.
What is the highest C79's short interest has been?
Since 2022, Chrysos's short interest peaked at 1.32% in May 2022 and bottomed at 0.00% in September 2023.
Where does this data come from?
All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2022. See our methodology.